Fortsæt til indhold

Main Navigation

Chr. Olesen Synthesis Chr. Olesen Synthesis
  • Products
  • Expertise
  • About
  • Contact

Arkiver: Timeline Stories

Timeline Post Type Description

Expected launch of Naloxone & Sugammadex

[…]

Læs mere… from Expected launch of Naloxone & Sugammadex

Expected launch of Apomorphine

[…]

Læs mere… from Expected launch of Apomorphine

Launch of buprenorphine Base

[…]

Læs mere… from Launch of buprenorphine Base

Launch of buprenorphine HCl

[…]

Læs mere… from Launch of buprenorphine HCl

Launch of dexamphetamine base

[…]

Læs mere… from Launch of dexamphetamine base

Launch of dexamphetamine sulphate

[…]

Læs mere… from Launch of dexamphetamine sulphate

Launch of hydromorphone HCl

[…]

Læs mere… from Launch of hydromorphone HCl

Ownership change 1995 – 1998

[…]

Læs mere… from Ownership change 1995 – 1998

Major event

BMS acquire plant with focus on developing a high-quality API production facility […]

Læs mere… from Major event

1970s – 1995

GEA Farmaceutisk Fabrik A/S […]

Læs mere… from 1970s – 1995

Indlægs navigation

  • 1
  • 2
  • »

Seneste kommentarer

    Contact

    Chr. Olesen Synthesis A/S
    Kanalholmen 8-12
    DK-2650 Hvidovre
    Denmark

    Tel.: +45 3679 4500
    E-mail: info@cosynthesis.dk

    Links

    • Products
    • Expertise
    • About
    • Contact

    About

    Chr. Olesen Synthesis is focusing on controlled substances and molecules like Buprenorphine, Dexamphetamine & Hydromorphone. In addition we can offer a selection of other APIs and advanced intermediates.

    Legal

    Privacy Policy / Cookies Whistleblowerordningen
    ©2023 Chr. Olesen Synthesis